Pulse oximetry

Masimo to Present in UBS Global Healthcare Virtual Conference

Retrieved on: 
Wednesday, May 19, 2021
Biotechnology, Health, Medical devices, Medicine, Clinical medicine, Masimo, Health care, Pulse oximetry, XC2

b'Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021 at 2:00 p.m. Eastern Time.

Key Points: 
  • b'Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021 at 2:00 p.m. Eastern Time.
  • A live webcast of the presentation will be available on the Masimo website at www.masimo.com .
  • Masimo SET\xc2\xae Measure-through Motion and Low Perfusion\xe2\x84\xa2 pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.
  • Masimo hospital automation and connectivity solutions are centered around the Iris\xc2\xae platform, and include Iris Gateway\xe2\x84\xa2, Patient SafetyNet, Replica\xe2\x84\xa2, Halo ION\xe2\x84\xa2, UniView\xe2\x84\xa2, and Doctella\xe2\x84\xa2.

A Higher Standard in Mobile Respiratory Health Monitoring

Retrieved on: 
Wednesday, May 19, 2021
Medicine, Clinical medicine, Medical monitoring, Technology, Cardiology, Pulse oximetry, LinkedIn Pulse, Bluetooth

The app uses a BYOPO approach allowing users to connect to the most popular and widely available Bluetoothpulse oximeters.

Key Points: 
  • The app uses a BYOPO approach allowing users to connect to the most popular and widely available Bluetoothpulse oximeters.
  • At launch, the Pulse Oximetry app will support 44 different Bluetooth pulse oximeter models from 26 different brand names, including spot check only devices.
  • With support for many more in coming updates.\nThe easy to use interface underscores some of the app's powerful features and functions.
  • The monitor is the heart of the app with all the information viewable at a glance and device controls and settings readily accessible.

Generex Biotechnology Subsidiary NuGenHealth Contracts with Westside Medicine & Cardiology, Inc. to Provide Remote Patient Monitoring (RPM) Services

Retrieved on: 
Tuesday, May 11, 2021
Medicine, Medical specialties, Clinical medicine, Medical monitoring, Pulse oximetry, Blood glucose monitoring, Monitoring

NuGenHealth will also supply WM&C with Bluetooth connected blood pressure monitors, electronic scales, glucose monitors, and pulse oximeters for their eligible patient population.

Key Points: 
  • NuGenHealth will also supply WM&C with Bluetooth connected blood pressure monitors, electronic scales, glucose monitors, and pulse oximeters for their eligible patient population.
  • Remote patient monitoring is a service that was positioned for significant growth as the pandemic has accelerated the practice of remote patient monitoring to improve outcomes.
  • We have selected NuGenHealth because the software is easy to install and maintain, has a user-friendly interface, and provides efficiencies in patient management.
  • Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.\n'

NONIN MEDICAL’S CO-PILOT RECOGNIZED IN FAST COMPANY’S 2021 WORLD CHANGING IDEAS AWARDS

Retrieved on: 
Monday, May 10, 2021
Medical specialties, Medicine, Clinical medicine, Hemoglobins, Cardiology, Medical monitoring, Pulse oximetry, Respiratory physiology, Methemoglobin, Monitoring, Carboxyhemoglobin

b'MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) -- Nonin Medical, a global leader in noninvasive medical monitoring and the manufacturer of the CO-Pilot\xe2\x84\xa2 Wireless Handheld Multi-Parameter System, received an honorable mention in Fast Company\xe2\x80\x99s 5th annual World Changing Ideas Awards in the health category.

Key Points: 
  • b'MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) -- Nonin Medical, a global leader in noninvasive medical monitoring and the manufacturer of the CO-Pilot\xe2\x84\xa2 Wireless Handheld Multi-Parameter System, received an honorable mention in Fast Company\xe2\x80\x99s 5th annual World Changing Ideas Awards in the health category.
  • It offers reliable readings to allow for improved first responder patient care or any emergency setting outside of the hospital.
  • The CO-Pilot simultaneously tracks patient pulse oximetry (SpO2), pulse rate, carboxyhemoglobin (COHb) and methemoglobin (MetHb); cerebral and tissue oximetry (rSO2) can be measured using an additional sensor.\nThe World Changing Ideas Awards recognize innovators in categories such as Health & Wellness and AI & Data.
  • To learn more, visit nonin.com .\nABOUT THE WORLD CHANGING IDEAS AWARDS:\nWorld Changing Ideas is one of Fast Company\xe2\x80\x99s major annual awards programs and is focused on social good, seeking to elevate finished products and brave concepts that make the world better.

Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting Mortality

Retrieved on: 
Monday, May 10, 2021
General Health, Medical devices, Hospitals, Health, Pharmaceutical, Medical specialties, Medicine, Clinical medicine, Intensive care medicine, Medical emergencies, Anesthesia, Cardiology, Medical monitoring, Pulse oximetry, Monitoring, Septic shock, Lactic

The researchers found that O3 trends correlated significantly with a variety of other hemodynamic variables and lactic acid levels commonly used in the monitoring of septic shock patients.

Key Points: 
  • The researchers found that O3 trends correlated significantly with a variety of other hemodynamic variables and lactic acid levels commonly used in the monitoring of septic shock patients.
  • The most important observation from this study is the significant correlation between NIRS oximetry readings and hemodynamic variables, especially lactic acid [and] central venous oxygen saturation in patients experiencing shock.
  • Our mission is to improve patient outcomes, reduce the cost of care, and take noninvasive monitoring to new sites and applications.
  • Inpatient Respiratory Arrest Associated With Sedative and Analgesic Medications: Impact of Continuous Monitoring on Patient Mortality and Severe Morbidity.

Generex Biotechnology Subsidiary NuGenHealth Contracts with Florida Health Care Associates to Provide Remote Patient Monitoring (RPM) Services

Retrieved on: 
Thursday, May 6, 2021
Medicine, Medical specialties, Clinical medicine, Medical monitoring, Communication, Forward-looking statement, Pulse oximetry, Blood glucose monitoring, Monitoring

NuGenHealth will also supply FHCA with Bluetooth connected blood pressure monitors, electronic scales, glucose monitors, and pulse oximeters for their eligible patient population.

Key Points: 
  • NuGenHealth will also supply FHCA with Bluetooth connected blood pressure monitors, electronic scales, glucose monitors, and pulse oximeters for their eligible patient population.
  • Remote patient monitoring is a service that was positioned for significant growth as the pandemic has accelerated the practice of remote patient monitoring to improve outcomes.
  • Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
  • Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.\n'

Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy

Retrieved on: 
Monday, May 3, 2021
General Health, Pharmaceutical, Health, Medical devices, Medicine, Branches of biology, Clinical medicine, Medical monitoring, Cardiovascular physiology, Masimo, Pulse oximetry, XC2, Preload, CO-oximeter

PVi was measured using a Masimo Radical-7\xc2\xae Pulse CO-Oximeter\xc2\xae with a pulse oximetry sensor attached to the finger.

Key Points: 
  • PVi was measured using a Masimo Radical-7\xc2\xae Pulse CO-Oximeter\xc2\xae with a pulse oximetry sensor attached to the finger.
  • Preload responsiveness was defined as a \xe2\x89\xa5 10% increase in SV after PLR.
  • A fluid challenge was then conducted by administering a 250-mL saline solution to patients who were found to be preload responders (12 of the 20 patients).
  • SV/CO and PVi were measured again after the fluid challenge in these patients.\nThe researchers found that preload responders showed higher baseline PVi values and \xce\x94PVi after PLR.

Global $6.60 Billion Pulse Oximeters and Spirometers Market Opportunities and Strategies, 2015-2019, 2023F, 2025F, 2030F

Retrieved on: 
Wednesday, April 28, 2021
Medicine, Clinical medicine, Health care, Cardiology, Medical monitoring, Pulse oximetry, Masimo, Spirometer, Compound annual growth rate

b'DUBLIN, April 28, 2021 /PRNewswire/ -- The "Pulse Oximeters and Spirometers Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com\'s offering.\nPulse Oximeters and Spirometers Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global pulse oximeters and spirometers market.\nThe global pulse oximeters and spirometers market reached a value of nearly $2,603.8 million in 2019, having grown at a compound annual growth rate (CAGR) of 7.5% since 2015, and is expected to grow at a CAGR of 10.9% to nearly $3,939.0 million by 2023.

Key Points: 
  • b'DUBLIN, April 28, 2021 /PRNewswire/ -- The "Pulse Oximeters and Spirometers Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com\'s offering.\nPulse Oximeters and Spirometers Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global pulse oximeters and spirometers market.\nThe global pulse oximeters and spirometers market reached a value of nearly $2,603.8 million in 2019, having grown at a compound annual growth rate (CAGR) of 7.5% since 2015, and is expected to grow at a CAGR of 10.9% to nearly $3,939.0 million by 2023.
  • Low per capita healthcare expenditure, lack of awareness and training, queries regarding the accuracy of readings, and insufficient information about spirology are major factors that could hinder the growth of the pulse oximeters and spirometers market in the future.\nThe pulse oximeters and spirometers market is relatively concentrated.
  • The top ten competitors in the market made up to 40.13% of the total market in 2019.
  • Major players in the market include Masimo Corporation, Medtronic plc, Koninklijke Philips N.V., Halma plc and Vyaire Medical.\n'

NuvoAir Home Platform Expands to Include Cough Data

Retrieved on: 
Wednesday, April 28, 2021
Medicine, Clinical medicine, Cough, Technology, Pulse oximetry, Bluetooth

b'BOSTON, April 28, 2021 /PRNewswire/ -- NuvoAir , a leading digital health company for chronic disease management and decentralized clinical trials, is excited to release NuvoAir Cough, a mobile app that records coughs in the home setting.

Key Points: 
  • b'BOSTON, April 28, 2021 /PRNewswire/ -- NuvoAir , a leading digital health company for chronic disease management and decentralized clinical trials, is excited to release NuvoAir Cough, a mobile app that records coughs in the home setting.
  • Currently available on iOS only, the app uses the smartphone\'s microphone and an AI-powered algorithm to detect a single cough or burst of coughs.
  • "\nThe NuvoAir Home platform includes the Air Next, a CE certified and FDA approved bluetooth spirometer, as well as devices to measure physical activity, pulse oximetry, weight change, cough patterns, and air quality.
  • NuvoAir\'s decentralized clinical trial platform has been used in over 20 studies globally, in all phases of drug development, with over 2000 patients.\n'

Nonin Medical Celebrates 35 Years of Reinventing Healthcare through Pulse Oximetry Innovation

Retrieved on: 
Monday, April 26, 2021
Medicine, Medical specialties, Clinical medicine, Medical monitoring, Cardiology, Pulse oximetry, Monitoring

b'MINNEAPOLIS, April 26, 2021 /PRNewswire/ -- Nonin Medical, Inc., a global leader in noninvasive medical monitoring, is celebrating the 35th anniversary of its founding in 1986.

Key Points: 
  • b'MINNEAPOLIS, April 26, 2021 /PRNewswire/ -- Nonin Medical, Inc., a global leader in noninvasive medical monitoring, is celebrating the 35th anniversary of its founding in 1986.
  • Over the past three decades, Nonin has introduced dozens of groundbreaking medical monitoring solutions, including the first portable pulse oximeter and first fingertip pulse oximeter.
  • Nonin pulse oximeters, cerebral and tissue oximeters, capnographs, sensors, and software deliver dependable performance day after dayeven in challenging environments.
  • To learn more, visit nonin.com .\nView original content to download multimedia: http://www.prnewswire.com/news-releases/nonin-medical-celebrates-35-year...\n'